Cardioprotective Potential of Aqueous Extract of <i>Fumaria indica</i> on Isoproterenol-Induced Myocardial Infarction in SD Rats

Sajid, Aimen; Ahmad, Taseer; Ikram, Muhammad; Khan, Taous; Shah, Abdul Jabbar; Mahnashi, Mater H.; Alhasaniah, Abdulaziz Hassan; Al Awadh, Ahmed Abdullah; Almazni, Ibrahim Abdullah; Alshahrani, Mohammed Merae

doi:https://doi.org/10.1155/2022/2112956

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 2112956 | https://doi.org/10.1155/2022/2112956

Cardioprotective Potential of Aqueous Extract of Fumaria indica on Isoproterenol-Induced Myocardial Infarction in SD Rats

Aimen Sajid,¹Taseer Ahmad,^1,2Muhammad Ikram,¹Taous Khan,¹Abdul Jabbar Shah,¹Mater H. Mahnashi,³Abdulaziz Hassan Alhasaniah,⁴Ahmed Abdullah Al Awadh,⁴Ibrahim Abdullah Almazni,⁴and Mohammed Merae Alshahrani⁴

Academic Editor: Silvana Hrelia

Received23 Feb 2022

Revised02 May 2022

Accepted06 May 2022

Published31 May 2022

Abstract

Ischemic heart disease (IHD) treatments and preventions by using plant extract and its phytochemical constituents have achieved considerable attention globally due to its cardioprotective effects. This study is aimed at investigating the cardioprotective and vascular effects of Fumaria indica (F. indica) crude extract on isoproterenol- (ISO-) induced myocardial infarction (MI) in Sprague-Dawley (SD) rats. Rats treated with isoproterenol (85 mg/kg, s.c), administered. Twice at an interval of 24 h showed a significant ST-segment elevation in ECG, edema, and necrosis in histopathology and also in troponin I (cTnI), creatine phosphokinase (CPK), lactate dehydrogenase (LDH), and aspartate aminotransferase (AST). Pretreatment with F. indica (10, 30, and 100 mg/kg, p.o) for 21 days significantly reversed the effects of isoproterenol-induced ischemic changes in the ECG, levels of cTnI, CPK, LDH, and AST, and histopathological changes. In isolated rat atrial strips, F. indica induced negative chronotropic and inotropic effects which were not affected by pretreatment with atropine, excluding role of cardiac muscarinic receptors. Cumulative addition of the extract induced a vasorelaxant effect on phenylephrine-evoked contractions in isolated rat aortic rings, which remained unchanged when challenged with _L-NAME, excluding role of endothelial NO. However, extract of F. indica concentration dependently reversed contractions evoked with high K⁺, indicating calcium entry blocking effect. In conclusion, the F. indica extract is a cardioprotective remedy that ameliorates the isoproterenol-induced cardiotoxic effects and reverses cardiac ischemia, and the calcium antagonistic effect might be of useful in the treatment of MI.

1. Introduction

Cardiovascular diseases (CVDs) are the leading cause of chronic disability and premature death for all regions of the world, and ischemic heart disease (IHD) accounts for the majority of health lost to CVDs. Myocardial infarction (MI), also called heart attack, is the acute necrotic condition of the myocardium that occurs due to myocardial demand and coronary blood supply mismatch [1]. Coronary atherosclerosis with activated inflammation in the vascular wall may develop MI. Apart from the mechanisms mediating coronary artery occlusion and supply-demand mismatch, reactive oxygen species (ROS) play vital role in the injury following MI [2].

Although conventional medicine in cardiovascular disorders is effective but potentially associated serious adverse effects, expensive lifelong management and rebound phenomenon are still key challenges [3]. A wide array of plants and active principles with minimum side effects provide an alternative therapy for ischemic heart diseases such as Cichorium intybus [4], Ginkgo biloba [5], Nerium oleander Linn [6], and Terminalia arjuna [7].

Fumaria indica L. (F. indica) synonyms: F. parviflora and F. vaillantii belong to family “Papaveraceae” commonly found in plains and lower hills of Pakistan, Turkey, India, Afghanistan, Iran, and Central Asia. F. indica commonly known as Fumitory, Fumus, and Earth smoke in English and locally known as “Murghipal” and “Papra” [8]. Ethnomedicinal studies have gained much importance in recent years, bringing to lights the numerous little unknown and known medicinal uses especially of plant origins. F. indica has a long history of use as a blood purifier [9] and antihypertensive remedy [10] in traditional medicine and has been reported to possess hepatoprotective [11], spasmolytic and spasmogenic [12], antibacterial [13], anti-inflammatory [14], gastroprotective [15], antidengue [16], antidiabetic, antileishmanial [17], and antioxidant activity [18, 19]. Compounds that are responsible for these activities are mostly isoquinolinic alkaloids, among which protopine is the most frequently found [20]. Previous studies have shown that protopine possesses antihypertensive [21], antiarrhythmic [22], and smooth muscle relaxant effect [23]. Protopine also exhibits calcium channel antagonist activity [24]. Beside isoquinolinic alkaloids, F. indica also contains polyphenols and flavonoids [17]. Phenolics and flavonoids have ideal structural chemistry for quenching free radicals which make them imperative in fighting and preventing conditions like oxidative stress, cell death, and cytotoxicity [25]. Antioxidant and calcium channel blocking activity provides protective effects in ischemic heart diseases [26, 27]. However, the literature lacks investigation of F. indica in cardiac ischemia so the current study investigated the F. indica extract for its cardioprotective potential and its effect on isolated cardiac tissue and aorta.

2. Materials and Methods

2.1. Experimental Animals

Experiments were performed in accordance with the rulings of the Institute of Laboratory Animal Resources, Commission on Life sciences, National Research Council [28] and approved by the Ethical Committee of Pharmacy Department, CUI, Abbottabad Campus, Pakistan. Sprague-Dawley (SD) rats 200-250 g weight were kept at the animal house of the CUI, Abbottabad Campus, maintained at (23-25°C) under 12-hour light/dark cycle allowed with food and water ad libitum.

2.2. Drugs and Standards

Drugs used in this study were purchased from the source specified: pentothal sodium (Abbott Laboratories, Pakistan), isoproterenol hydrochloride, atropine sulfate, phenylephrine hydrochloride, potassium chloride, atenolol, and Nω-nitro-L-arginine methyl ester hydrochloride (_L-NAME) (Sigma Chemicals Company, USA). Analytical grade chemicals were used. All chemical stock solutions were made in distilled water and normal saline.

2.3. Extraction

The collected F. indica was rinsed with tap water to remove the associated dust and shade dried at ambient temperature (24-26°C) with occasional rotation. The dried material was grinded to obtain 1.5 kg of dried powder. The powdered material was then subjected to extraction using methanol as menstrum at ambient temperature. The soaked materials were stirred daily with stainless steel rod in order to avoid caking and to get uniform mixing. The soaking was performed for 21, 7, and 3 days, successively in order to fully exhaust the plant materials. Whatman filter paper and muslin cloth were used in order to remove the solid particles. The filtration was done using rotary evaporator and water bath set at 40°C. To obtain the final percentage yield of crude dried extract of F. indica, crude extract was dried in a fume hood [29].

2.4. Isoproterenol-Induced Myocardial Infarction Rat Model

SD rats were divided in to 6 groups having 5 rats in each. Group 1 served as control and was kept on normal saline. Group 2 received isoproterenol (85 mg/kg, s.c) on days 20 and 21. Groups 3–5 received 10, 30, and 100 mg/kg (p.o) respective doses of extract of F. indica for three weeks and isoproterenol (85 mg/kg, s.c) only on days 20 and 21. Group 6 received atenolol (10 mg/kg, s.c) for 3 weeks and isoproterenol (85 mg/kg, s.c) only on days 20 and 21. Twelve hours after isoproterenol last dose, all the rats were anesthetized with thiopental sodium (40-90 mg/kg, i.p) and ECG was recorded; biochemical parameters were identified, and histopathological study was also carried out.

2.5. Electrocardiography (ECG)

ECG measurement of SD rats was carried out in anesthetized rats, placed in a supine position from all the groups. After 30 min of complete anesthesia induction, acupuncture needle electrodes was inserted subcutaneously according to the lead II (right foreleg, left rear leg, and left foreleg) as per ECG scheme. ECG was recorded for 1 minute every 5 minutes in anesthetized rats by using a PowerLab connected with BioAmp and analyzed by the LabChart 7 software (ADInstrument, Australia). Each channel was amplified and sampled at a rate of 2 KHz and 5 mV range of a high-pass filter setting of 1 Hz. Alterations in ECG pattern (ST-segment depression or elevation) in experimental and normal rats were recorded and analyzed [30].

2.6. Biochemical Estimations

For biochemical estimation, serum was separated by centrifugation and cardiac markers such as troponin I (cTnI), creatine phosphokinase (CPK), lactate dehydrogenase (LDH), and aspartate aminotransferase (AST) which were estimated according to the procedure reported by [31–33].

2.7. Histopathological Examination

SD rats from all groups were sacrificed, and removed hearts were immediately fixed in buffered formalin (10%). Heart ventricular mass from apex to the base was sectioned and embedded (with paraffin) after dehydration with alcohol and xylene clearance. Staining of 5 μm thick histological sections was done with eosin and hematoxylin after obtaining from the paraffin blocks which were examined under light microscope.

2.8. Myocardial Infarction Determination by Direct Staining

Rat hearts were removed and frozen immediately, and from the apex towards the atrioventricular (AV) groove, thick slice of 3-5 mm was cut. The slice was incubated in 1% solution of 2,3,5-triphenyltetrazolium chloride (in phosphate buffer saline pH 7.4) for 20 min at 37°C. Examination of the sections was done under light, and photographs were taken [30].

2.9. Underlying Mechanism on Isolated Rat Atria

As described previously [34, 35], rats were sacrificed by cervical dislocation and atria were removed and mounted in tissue bath containing Kreb’s solution, aerated with carbogen gas (5% CO₂ in 95% O₂) at 32°C. 1 g resting tension was applied to each tissue, and equilibrium period of 10-15 min was allowed before studying the effect of different concentrations of extract of F. indica on spontaneous atrial contractions. The tissues were preincubated with atropine (1 μM) for 30 min to explore underlying mechanism. Changes in isometric tension of the atria via a force-displacement transducer connected to PowerLab Data Acquisition System were measured.

2.10. Vascular Effects in Isolated Rat Aorta

As described previously [36, 37], the descending thoracic aorta was isolated from the rats, transferred into the petri plate containing normal Kreb’s solution, and cleaned. Kreb’s solution was composed of the following (mM): glucose 11.7 (pH 7.4), KCL 4.7, NaHCO₃ 25.0, NaCl 118.2, CaCl₂ 2.5, MgSO₄ 1.2, and KH₂PO₄ 1.3. In tissue bath containing carbogen-aerated Kreb’s solution, aortic ring (3 mm) preparations were carefully hanged and attached to a force transducer, which was coupled with PowerLab Data Acquisition System (ADInstruments, Sydney, Australia). Stabilization period of 30-45 min was given to each aortic ring with a preload of 2 g by changing buffer every 15 min. Sustained contractions were induced by phenylephrine, and the cumulative addition of different concentrations (0.1–10 μg/mL) of the extract was made to determine effect on vascular tone. _L-NAME (10 μM) was used to determine role of vascular nitric oxide.

2.11. Statistical Analysis

All the values were expressed as . One-way ANOVA followed by Tukey’s test was used to test statistical significance through the GraphPad Prism software (GraphPad, San Diego, CA, USA). Differences were considered to be statistically significant when .

3. Results

3.1. Effect of F. Indica Extract on Electrocardiography (ECG) Parameters

Normal control rats were kept on normal diet, and drinking water showed no changes in the ECG pattern and ST segment (Figures 1(a) and 2), while isoproterenol-treated rats showed pathologic Q wave formation and significant ST-segment elevation (Figures 1(b) and 2). Restoration of normal ECG pattern occurred in atenolol (10 mg/kg) and F. indica extract (10, 30, and 100 mg/kg)-pretreated group in a dose-dependent manner.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 2

ST-segment changes of control and experimental animals. Group 1, control showed normal ST segment. Group 2, isoproterenol-treated showed significant ST-segment elevation. Group 3, F. indica crude extract 10 mg/kg + ISO. Group 4, F. indica 30 mg/kg + ISO. Group 5, F. indica 100 mg/kg + ISO showed marked reduction in ST elevation. Group 6, atenolol (10 mg/kg) + ISO-treated rats represent maximum reduction in ST-segment elevation. Values are expressed as . . Compared with control, , which represents the significant difference vs. control.

3.2. Effect of F. Indica Crude Extract on Cardiac Marker Enzymes

Qualitative estimation of cTnI in all rats of the control group was negative (Table 1), and the serum CPK, LDH, and AST concentrations were , , and IU/L as shown in Figure 3. Rats treated with isoproterenol showed positive cTnI and serum CPK , LDH , and AST IU/L as shown in Figure 3. Significant decreased in number of positive cTnI test cases (Table 1) and serum level of CPK , LDH , and AST IU/L (Figure 3) were observed in rats pretreated with F. indica (10 mg/kg). Rats pretreated with F. indica crude extract (30 mg/kg) showed less positive cTnI test cases (Table 1), and a significant serum reduction level of CPK , LDH , and AST IU/L (Figure 3) was observed. Pretreatment with F. indica crude extract (100 mg/kg) restored significantly the serum cardiac biomarker level alteration induced by ISO, such as significant decreased in the positive cTnI test cases (Table 1) and serum level of CPK , LDH , and AST IU/L (Figure 3). In addition, pretreatment with atenolol (10 mg/kg) also significantly decreased positive cTnI test cases and the serum level of the CPK , LDH , and AST IU/L (Figure 3).

Figure 3

Changes in the levels of creatine phosphokinase (CPK), lactate dehydrogenase (LDH), and aspartate transaminase (AST). Group 1, control; group 2, isoproterenol-induced MI group; group 3, F. indica extract-treated group (10 mg/kg); group 4, F. indica extract-treated group (30 mg/kg); group 5, F. indica extract-treated group (100 mg/kg); group 6, atenolol-treated group (10 mg/kg). Values are expressed as . . Compared with control, and , which represent the significant difference vs. control.

3.3. Effect of F. Indica Crude Extract on Histopathology and TTC Staining

In histopathological examination of the control group, normal architecture was observed (Figure 4(a)), whereas ISO-treated rats showed edema, inflammatory cell infiltration, and necrosis (Figure 4(b)). The animals pretreated with F. indica crude extract (Figures 4(c)–4(e)) showed much less intensity and distribution of edema, inflammatory cell infiltrations, and necrosis. TTC-stained brick red (dark region), an indicator of mitochondrial respiration, was observed in the heart tissues of the control (Figure 5(a)) and F. indica crude extract (10, 30, and 100 mg/kg)-treated group. In the ISO-treated group (Figure 5(b)), the unstained region indicates total necrosis. The heart tissue sections pretreated with F. indica crude extract (10, 30, and 100 mg/kg) (Figures 5(c)–5(e)) as compared with the ISO-treated group showed a lesser degree of unstained region.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 4

Effect of F. indica extract pretreatment on histopathological changes. (a) Heart tissue of a normal control showed normal cardiomyocytes (arrow) with one centrally placed nucleus. (b) The isoproterenol- (ISO-) treated group showed marked edema (arrow), inflammatory cell infiltration (star), and necrosis (four-point star). (c) Pretreatment with F. indica extract (10 mg/kg) + ISO showed minimum reduction of edema, inflammatory cell infiltration, and necrosis. (d) F. indica extract (30 mg/kg) + ISO produced moderate reduction of edema, inflammatory cell infiltration, and necrosis. (e) F. indica extract (100 mg/kg) + ISO produced maximum reduction of edema, inflammatory cell infiltration, and necrosis. (f) Atenolol (10 mg/kg) + ISO showed moderate reduction of edema, inflammatory cell infiltration, and necrosis.

Figure 5

Effect of F. indica extract on representative photomicrograph of heart tissues dyed with 2,3,5-triphenyltetrazolium chloride. (a) The control group showed stained brick red region (dot), an indicator of viable tissue, (b) the isoproterenol- (ISO-) induced MI group showed marked unstained region (notched arrow), an indicator of total necrosis, (c) F. indica extract 10 mg/kg + ISO showed mild decrease in unstained region, (d) F. indica extract 30 mg/kg + ISO showed moderate decrease in unstained region, (e) F. indica extract 100 mg/kg + ISO showed marked decrease in unstained region, and (f) atenolol 10 mg/kg + ISO showed moderate decrease in unstained region. LV: left ventricle; RV: right ventricle.

3.4. In Vitro Rat Right Atrial Study

Right atrial strips from normal rats were used to investigate chronotropic and inotropic effects of F. indica. The crude extract has shown dose-dependent decrease in force of contraction (100%) and heart rate (100%) (Figures 6(a) and 6(b)). In atropine-pretreated tissues, decrease in force of contraction and heart rate was shown to be 100%, respectively (Figures 6(c) and 6(d)).

(a)

(b)

(c)

(d)

3.5. In Vitro Vascular Reactivity Studies

To perform vascular reactivity studies, aortae isolated from normal rats were used. The cumulative addition of F. indica crude extract against phenylephrine precontractions produced relaxation with value of 0.1 mg/mL (0.1-0.2) (Figure 7(a)). _L-NAME (10 μM)-pretreated rings showed relaxation with value of 0.10 mg/mL (0.1-0.2) (Figure 7(b)) precontracted with PE (1 μM). High K⁺-contracted tissues showed complete relaxation with F. indica crude extract (Figure 7(c)).

(a)

(b)

(c)

4. Discussion

Isoproterenol (ISO), a synthetic nonselective β-adrenoceptor agonist, has been found to induce acute MI in rats at high doses. Isoproterenol leads to myocardial hyperfunction due to increase both in chronotropism and inotropism leading to imbalance between oxygen demand and supply to cardiomyocytes [38]. Isoproterenol results in increase in intracellular calcium level and oxidative stress through activation of cyclic adenosine monophosphate (cAMP) signaling pathway [39]. Isoproterenol results in the generation of highly cytotoxic oxygen derived free radicals which cause lipid membrane peroxidation, leading to both structural and functional myocardial cell injury and death [40]. The pathophysiological changes following isoproterenol administration are comparable to those taking place in human myocardial alterations [33].

For the definite MI diagnosis, evolving pattern of ECG abnormalities is the main criterion generally used [41]. In isoproterenol-induced rats significant ECG pattern alteration were observed when compared with normal rats. High dose of isoproterenol caused myocardial necrosis due to severe stress in the myocardium, deep Q wave and ST elevation in ECG, and structural and conduction disturbances in the heart. The typical finding was the ST-segment elevation which is an indicative sign of acute ischemic tissue injury in the transmural region of myocardium [42]. Isoproterenol-induced increased ROS and calcium influx into the myocardium result in myocyte necrosis and the collapse of cell membrane permeability [43]. Increase ROS production results in increased mitochondrial membrane permeability, outer membrane rupture, and the release of apoptotic signaling molecules [44]. Activation of calcium-dependent phospholipases, proteases enzymes, and high energy phosphate depletion by calcium overload affects the membrane [45, 46]. ECG abnormalities such as formation of pathological Q wave, ST-segment elevation, and conduction disturbances in isoproterenol-treated rats might be characterized by the consecutive loss of function of the ischemic myocardial cell membrane [47]. F. indica extract pretreatment reversed the ISO-induced altered ECG patterns, suggesting membrane protective effect, which was dose-dependent. This membrane protective effect might be due to the antioxidant and calcium channel blocking activity of F. indica. Significant restoration of ECG pattern was obtained with 100 mg/kg dose of F. indica. The cardioprotective action of F. indica was further confirmed. As ECG pattern can show uncertain patterns, estimation of serum biochemical markers can be helpful for confirming MI.

Heart contains diagnostic marker enzymes like cTnI, CPK, LDH, and AST in an abundant concentration, and it releases its content into the extracellular fluid once the heart is metabolically damaged. Significant serum level elevation of diagnostic cardiac markers (cTnI, CPK, LDH, and AST) was noticed in the isoproterenol-treated rats. Increased in the cardiac marker enzymes is the indication of isoproterenol-induced necrotic damage to the myocardial membrane which is in the line with the earlier reports [48]. Free radical generation and stimulation of lipid peroxidation by isoproterenol are the causative factor for the irreversible myocardial cell membrane damage and leakage of cardiac injury biomarkers [49].

Cardiac troponin is specific to the myocardium and considered as gold standard biomarker for diagnosing MI. As compared to troponin C (TnC) and troponin T (TnT), troponin I (cTnI) is more sensitive to cardiac injury. In MI, circulating cTnI level in the serum rises within 30 min and reaches to peak level at 18-24 h indicating myocyte apoptosis [50]. F. indica pretreatment significantly decreases the serum cTnI in isoproterenol-induced MI rats. It demonstrated that F. indica could restrict the cTnI leakage from the myocardium by maintaining structural and functional integrity and permeability of the cardiac membrane. CPK is a brain and heart muscle-specific enzyme and usually elevated as the result of myocarditis, cardiac insufficiency, arrhythmias, and myocardial infarction. Over a period of 24 h, CPK can be measured several times [51]. Isoproterenol results in the increase in serum CPK level due to the myocardial cell membrane damage and leakage of enzyme. The significant decreased in the serum level of CPK in isoproterenol-induced MI rats was observed with pretreatment with F. indica. Maximum decrease (41%) in the serum CPK level was observed with 100 mg/kg indicating membrane protective effect of F. indica.

LDH high concentration in the blood is an indicative of tissue damage and inflammatory changes in the heart. F. indica significantly reduces (45%) the serum LDH level in isoproterenol-treated rats. LDH is a cytosolic enzyme, which is essentially present in all the tissues involved in glycolysis [52]. LDH is not a specific marker for MI and is elevated within 24-72 h following MI and in 3-4 days reaches a peak concentration [53]. AST is a sensitive indicator of liver cell injury and is also helpful for diagnosing other diseases. In normal physiological condition, it is usually present in low concentration in the serum; however, increase is observed after MI. The probability of MI in individuals with high AST level is nearly 17 times more than the normal individuals. In 1958, AST was one of the first cardiac biomarkers used for MI diagnosis but because of weak specificity for the matter, it is no longer used as a gold standard [54]. F. indica significantly decreases (32%) serum level of AST. The significant fall in the serum level of cardiac markers (cTnI, CPK, LDH, and AST) indicating that F. indica ameliorates isoproterenol-induced cardiac injury. It demonstrated that F. indica could restrict these enzyme leakages by maintaining cardiac membrane integrity and permeability. However, in order to obtain the comprehensive view of the myocardial tissue architecture of isoproterenol-induced MI rats pretreated with F. indica, histopathological study was performed.

Histopathology provides wealth of tissue information. The preliminary histopathological examination of the isoproterenol-treated rat myocardium showed edema, inflammatory cell infiltration, necrosis, and separation of cardiac muscle fibers. Overproduction of ROS by isoproterenol can cause severe cellular function impairment and necrotic lesions in the myocardium of rats. Isoproterenol generates superoxide radicals at the site of damage and modulates superoxide dismutase, glutathione peroxidase, and catalase [55]. Pretreated groups with F. indica extract (100 mg/kg) showed significantly reversed edema, inflammatory cell infiltration, and necrosis as seen with the isoproterenol-treated group. Previous study has shown F. indica exhibits antioxidant activity by scavenging free radicals and decrease malondialdehyde (MDA), an indicator of lipid peroxidation by increase in the level of free radical scavenging enzymes such as glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) [56]. Myocardial necrosis is also detected by using stain 2,3,5-triphenyltetrazolium chloride (TTC) with which LDH of the viable myocardial tissue forms red formazan precipitate in the presence of an intact dehydrogenase enzyme system whereas the infarcted myocardium fails to stain with TTC. Consequently, TTC-unstained regions correspond to the total necrotic areas [57]. In isoproterenol-treated rats, large unstained region with more necrotic patches was observed. Significant lesser degree of unstained region was observed with pretreatment with F. indica in isoproterenol-treated rats showing greater tissue viability with less necrotic tissues. The maximal tissue protection was observed with 100 mg/kg dose of F. indica. The cardioprotective action of F. indica was further confirmed by its effect on rat atria.

To have insight into the effects of extracts on cardiac muscles, F. indica crude extract was further tested on isolated rat atrial strips. Extract completely repressed force (negative inotropic) and rate (negative chronotropic) of spontaneous atrial contractions. Thus, it is suggested that the cardioprotective effects of F. indica against isoproterenol-induced MI might be due to negative inotropic and chronotropic effects, which restore coronary blood supply to the myocardium. To determine the vascular effects of F. indica, isolated rat aortic rings were used.

When tested on vascular preparation precontracted with phenylephrine, F. indica extract produced complete relaxation at the concentration of 1.0 mg/ml; this relaxation was not modified with _L-NAME a nitric oxide synthase inhibitor [58], thus excluding the role of nitric oxide pathway. However, cumulative addition of F. indica extract relaxed high K⁺-induced contractions at similar doses. High K⁺ increases intracellular level of Ca⁺² from voltage-dependent Ca⁺² channels [59]. The relaxation of high K⁺ precontraction by the extract suggests that the vasorelaxant effect possibly mediated through calcium channel blockade. These findings partly explain the negative chronotropic and ionotropic effects of F. indica. Previous studies have shown that alkaloids, flavonoids, and phenols exhibit cardioprotective activity [60]. Therefore, the content of alkaloids, flavonoids, and phenols reported in F. indica extract might be responsible for myocardial cell membrane protective activity. Protopine an alkaloid present in F. indica might be contributed to the cardioprotective effect and can be further investigated.

5. Conclusion

These findings indicate that F. indica possesses cardioprotective and vasorelaxant effects. F. indica offers protection to myocardium by maintaining ECG patterns, cardiac marker enzymes, and histopathological parameters. These effects could be due to its negative inotropic and chronotropic effects, antioxidant, and membrane-stabilizing properties. Vasodilatory effects is mediated by inhibiting calcium released and decreasing cardiac rate and force of contraction. These findings may be helpful to justify further investigations concerning F. indica cardioprotective effects. For further evaluation, the use of bovine coronary artery would be the better approach to have more specific insight in to the mechanisms. There is need to explore plant constituents which are responsible for its cardioprotective and vasorelaxant effects.

Data Availability

Data is available on request to the corresponding author, Dr. Abdul Jabbar Shah, Email: [email protected].

Conflicts of Interest

The authors have no conflict of interest.

Authors’ Contributions

Aimen Sajid, Taseer Ahmad, and Abdul Jabbar Shah designed the study. Aimen Sajid and Muhammad Ikram performed the experiment, Abdul Jabbar Shah and Taous Khan supervised the study, data were analyzed and reviewed by Abdul Jabbar Shah and Taseer Ahmad, Mater H. Mahnashi and Abdulaziz Hassan Alhasaniah collected study data and performed statistical analysis and visualization, and Ahmed Abdullah Al Awadh, Mohammed Merae Alshahrani, and Ibrahim Abdullah Almazni contributed to the writing and proofreading of the manuscript.

Acknowledgments

The authors sincerely want to thank the Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus for providing Lab facilities.

References

D. P. De Bono and N. A. Boon, “Diseases of the Cardiovascular System,” In: Davidson’s Principle of Practise of Medicine, Churchill Livingstone, Hong Kong, pp. 249–340, 1992.
View at: Google Scholar
K. Thygesen, J. S. Alpert, and H. D. White, “Universal definition of myocardial infarction,” Journal of the American College of Cardiology, vol. 50, no. 22, pp. 2173–2195, 2007.
View at: Publisher Site | Google Scholar
C. Liu and Y. Huang, “Chinese herbal medicine on cardiovascular diseases and the mechanisms of action,” Frontiers in Pharmacology, vol. 7, pp. 1–21, 2016.
View at: Publisher Site | Google Scholar
R. M. K. Nayeemunnisa, “Cardioprotective effects of Cichorium intybus in ageing myocardium of albino rats,” Current Science, vol. 4, pp. 941–943, 2003.
View at: Google Scholar
V. S. Panda and S. R. Naik, “Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents,” Alternative Medicine Review, vol. 14, no. 2, pp. 161–171, 2009.
View at: Google Scholar
V. Gayathri, S. Ananthi, C. Chandronitha, G. Ramakrishnan, R. L. Sundaram, and H. R. Vasanthi, “Cardioprotective effect of Nerium oleander flower against isoproterenol-induced myocardial oxidative stress in experimental rats,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 16, no. 1, pp. 96–104, 2011.
View at: Publisher Site | Google Scholar
S. Bishop and S. J. Liu, “Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin,” Phytomedicine, vol. 36, pp. 210–216, 2017.
View at: Publisher Site | Google Scholar
J. Khan and R. A. Qureshi, “Taxonomic revision of Fumaria Indica (Fumariaceae) from Pakistan,” International Journal of Multidisciplinary Sciences and Engineering, vol. 4, pp. 24–26, 2013.
View at: Google Scholar
A. M. Rozina, M. Zafar, M. Qasim, and S. Zainulabidin, “Ethnomedicinal uses of plants for blood purification in disitrict Swabi, Khyber Pakhtunkhwa, Pakistan,” Journal of Rural Development and Agriculture, vol. 2, pp. 41–56, 2017.
View at: Google Scholar
L. Ahmad, A. J. Semotiuk, Q. R. Liu et al., “Antihypertensive plants of rural Pakistan: current use and future potential,” Journal of Complementary Medicine Research, vol. 7, no. 2, pp. 138–153, 2018.
View at: Publisher Site | Google Scholar
K. S. Rao and S. H. Mishra, “Hepatoprotective activity of the whole plants of Fumaria indica,” Indian Journal of Pharmaceutical Sciences, vol. 59, pp. 165–170, 1997.
View at: Google Scholar
A. H. Gilani, S. Bashir, K. H. Janbaz, and A. Khan, “Pharmacological basis for the use of Fumaria indica in constipation and diarrhea,” Journal of Ethnopharmacology, vol. 96, no. 3, pp. 585–589, 2005.
View at: Publisher Site | Google Scholar
J. Parekh and S. Chanda, “In-vitro screening of antibacterial activity of aqueous and alcoholic extracts of various Indian plant species against selected pathogens from Enterobacteriaceae,” African Journal of Microbiology Research, vol. 1, pp. 92–99, 2007.
View at: Google Scholar
A. Shakya, G. K. Singh, S. S. Chatterjee, and V. Kumar, “Role of fumaric acid in anti-inflammatory and analgesic activities of a Fumaria indica extracts,” Journal of Intercultural Ethnopharmacology, vol. 3, no. 4, pp. 173–178, 2014.
View at: Publisher Site | Google Scholar
A. Shakya, U. K. Soni, G. Rai, S. S. Chatterjee, and V. Kumar, “Gastro-protective and Anti-stress efficacies of monomethyl fumarate and a Fumaria indica extract in chronically stressed rats,” Cellular and Molecular Neurobiology, vol. 36, no. 4, pp. 621–635, 2016.
View at: Publisher Site | Google Scholar
I. Qaddir, N. Rasool, W. Hussain, and S. Mahmood, “Computer aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies,” Journal of Vector Borne Diseases, vol. 54, no. 3, pp. 255–262, 2017.
View at: Publisher Site | Google Scholar
B. Nasir, M. Ahmad, S. S. Zahra, H. Fatima, and T. Ur-Rehman, “Pharmacological evaluation of Fumaria indica (hausskn) Pugsley; a traditionally important medicinal plant,” Pakistan Journal of Botany, vol. 49, pp. 119–132, 2017.
View at: Google Scholar
H. Fazal, N. Ahmad, and M. A. Khan, “Physicochemical, phytochemical evaluation and DPPH scavenging antioxidant potential in medicinal plants used for herbal formulation in Pakistan,” Pakistan Journal of Botany, vol. 43, pp. 63–67, 2011.
View at: Google Scholar
R. Razavi and R. E. Kenari, “Antioxidant evaluation of Fumaria parviflora L. extract loaded nanocapsules obtained by green extraction methods in oxidative stability of sunflower oil,” Journal of Food Measurement and Characterization, vol. 15, no. 3, pp. 2448–2457, 2021.
View at: Publisher Site | Google Scholar
R. Păltinean, A. Mocan, L. Vlase et al., “Evaluation of polyphenolic content, antioxidant and diuretic activities of six Fumaria species,” Molecules, vol. 22, no. 4, p. 639, 2017.
View at: Publisher Site | Google Scholar
D. Y. Wang, “Effects of alkaloids of Corydalis decumbens on cerebral and peripheral circulation in the dog,” Chinese Journal of Modern Developments in Traditional Medicine, vol. 6, no. 8, pp. 454–477, 1986.
View at: Google Scholar
Z. Lu, D. Wang, and Z. Chen, “Effects of protopine on experimental arrhythmia,” Chines Pharmaceutical Journal-Bejing, vol. 30, pp. 81–81, 1995.
View at: Google Scholar
Y. H. Huang, Z. Z. Zhang, and J. X. Jiang, “Relaxant effects of protopine on smooth muscles,” Acta Pharmacologica Sinica, vol. 12, no. 1, pp. 16–19, 1991.
View at: Google Scholar
F. N. Ko, T. S. Wu, S. T. Lu, Y. C. Wu, T. F. Huang, and C. M. Teng, “Ca2+-channel blockade in rat thoracic aorta by protopine isolated from Corydalis tubers,” Journal of pharmacological sciences, vol. 58, no. 1, pp. 1–9, 1992.
View at: Publisher Site | Google Scholar
H. J. Kim, F. Chen, X. Wang, and J. H. Choi, “Effect of methyl jasmonate on phenolics, isothiocyanate, and metabolic enzymes in radish sprout (Raphanus sativus L.),” Journal of Agricultural and Food Chemistry, vol. 54, no. 19, pp. 7263–7269, 2006.
View at: Publisher Site | Google Scholar
F. Follath, “The role of calcium antagonists in the treatment of myocardial ischemia,” American Heart Journal, vol. 118, no. 5, pp. 1093–1097, 1989.
View at: Publisher Site | Google Scholar
D. Bandyopadhyay, A. Chattopadhyay, G. Ghosh, and A. G. Datta, “Oxidative stress-induced ischemic heart disease: protection by antioxidants,” Current Medicinal Chemistry, vol. 11, no. 3, pp. 369–387, 2004.
View at: Publisher Site | Google Scholar
National Research Council, Guide for the care and use of laboratory animals, Washington DC: The National Academies Press, edt. 8 edition, 2011.
E. M. Williamson, D. T. Okpako, and F. J. Evans, Pharmacological methods in phytotherapy research: selection, preparation and pharmacological evaluation of plant material, John Wiley & sons, New York, 1996.
R. Tiwari, M. Mohan, S. Kasture, A. Maxia, and M. Ballero, “Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction in Wistar rats,” Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, vol. 23, no. 10, pp. 1361–1366, 2009.
View at: Publisher Site | Google Scholar
A. Karmen, F. Wroblewski, and J. S. LaDue, “Transaminase activity in human blood,” The Journal of Clinical Investigation, vol. 34, pp. 126–133, 1955.
View at: Google Scholar
R. P. MacDonald, J. R. Simpson, and E. Nossal, “Serum lactic dehydrogenase a diagnostic aid in myocardial infarction,” Journal of the American Medical Association, vol. 165, no. 1, pp. 35–40, 1957.
View at: Publisher Site | Google Scholar
M. Rajadurai and P. S. M. Prince, “Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats,” Toxicology, vol. 230, no. 2-3, pp. 178–188, 2007.
View at: Publisher Site | Google Scholar
N. Yoshihisa, K. Ichihara, R. Yoshida, and Y. Abiko, “Positive inotropic and negative chronotropic effects of (-) cis-diltiazem in rat isolated atria,” British Journal of Pharmacology, vol. 105, no. 3, pp. 696–702, 1992.
View at: Publisher Site | Google Scholar
A. J. Shah and A. H. Gilani, “Bronchodilatory effect of _Acorus calamus_ (Linn.) is mediated through multiple pathways,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 471–477, 2010.
View at: Publisher Site | Google Scholar
R. F. Furchgott and J. V. Zawadski, “The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine,” Nature, vol. 288, no. 5789, pp. 373–376, 1980.
View at: Publisher Site | Google Scholar
U. Salma, T. Khan, and A. J. Shah, “Antihypertensive efficacy of extract of Hedera helix in high salt-induced hypertensive Sprague-Dawley rats,” Asian Pacific Journal of Tropical Medicine, vol. 11, no. 8, pp. 473–479, 2018.
View at: Publisher Site | Google Scholar
C. D. Lucia, A. Eguchi, and W. J. Koch, “New insights in cardiac β-adrenergic signaling during heart failure and aging,” Frontiers in Pharmacology, vol. 9, p. 904, 2018.
View at: Publisher Site | Google Scholar
D. Mann, R. Kent, B. Parsons, and G. Cooper, “Adrenergic effects on the biology of the adult mammalian cardiocyte,” Circulation, vol. 85, no. 2, pp. 790–804, 1992.
View at: Publisher Site | Google Scholar
P. K. Singal, N. Kapur, K. S. Dhillon, R. E. Beamish, and N. S. Dhalla, “Role of free radicals in catecholamine-induced cardiomyopathy,” Canadian Journal of Physiology and Pharmacology, vol. 60, no. 11, pp. 1390–1397, 1982.
View at: Publisher Site | Google Scholar
D. D. Miller, Acute Myocardial Infarction, CLS Inc. Press, New York, 1991.
P. R. Maroko, P. Libby, B. E. Sobel et al., “Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion,” Circulation, vol. 45, no. 6, pp. 1160–1175, 1972.
View at: Publisher Site | Google Scholar
S. Mallov, “Effect of cardiotoxic concentrations of catecholamines on Na⁺‒Ca2⁺ exchange in cardiac sarcolemmal vesicles,” Experimental and Molecular Pathology, vol. 40, no. 2, pp. 206–213, 1984.
View at: Publisher Site | Google Scholar
J. N. Weiss, P. Korge, H. M. Honda, and P. Ping, “Role of the mitochondrial permeability transition in myocardial disease,” Circulation Research, vol. 93, no. 4, pp. 292–301, 2003.
View at: Publisher Site | Google Scholar
E. Nirdlinger and P. Bramante, “Subcellular myocardial ionic shifts and mitochondrial alterations in the course of isoproterenol-induced cardiopathy of the rat,” Journal of Molecular and Cellular Cardiology, vol. 6, no. 1, pp. 49–56, 1974.
View at: Publisher Site | Google Scholar
E. Titus, “A molecular biologic approach to cardiac toxicology,” Advances in Experimental Medicine and Biology, vol. 161, pp. 509–518, 1983.
View at: Publisher Site | Google Scholar
R. P. Holland and H. Brooks, “TQ-ST segment mapping: Critical review and analysis of current concepts,” The American Journal of Cardiology, vol. 40, no. 1, pp. 110–129, 1977.
View at: Publisher Site | Google Scholar
V. Sathish, V. Vimal, K. K. Ebenezar, and T. Devaki, “Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol-induced myocardial infarction in rats,” Journal of Pharmacy and Pharmacology, vol. 54, no. 1, pp. 133–137, 2002.
View at: Publisher Site | Google Scholar
P. S. M. Prince and A. J. Roy, “p-Coumaric acid attenuates apoptosis in isoproterenol-induced myocardial infarcted rats by inhibiting oxidative stress,” International Journal of Cardiology, vol. 168, no. 4, pp. 3259–3266, 2013.
View at: Publisher Site | Google Scholar
L. Ni and X. H. Wehrens, “Cardiac troponin I—more than a biomarker for myocardial ischemia,” Annals of Translational Medicine, vol. 6, no. S1, p. 17, 2018.
View at: Publisher Site | Google Scholar
G. Abi Beaulah, A. Mohamed Sadiq, V. Sivakumar, and R. Jaya Santhi, “Cardioprotective activity of methanolic extract of Croton sparciflorus on isoproterenol induced myocardial infarcted Wistar albino rats,” Journal of Medicinal Plants, vol. 2, pp. 1–8, 2014.
View at: Google Scholar
G. L. Plaa and H. J. Zimmerson, “Evaluation of hepatotoxicity: physiological and biochemical measures of hepatic function,” Comprehensive Toxicology, vol. 9, pp. 97–109, 1997.
View at: Google Scholar
S. Mythili and N. Malathi, “Diagnostic markers of acute myocardial infarction,” Biomedical Reports, vol. 3, no. 6, pp. 743–748, 2015.
View at: Publisher Site | Google Scholar
A. Shamshirian, R. Alizadeh-Navaei, S. Abedi et al., “Levels of blood biomarkers among patients with myocardial infarction in comparison to control group,” Ethiopian Journal of Health Sciences, vol. 30, no. 1, pp. 5–12, 2020.
View at: Publisher Site | Google Scholar
P. Tappia, T. Hata, L. Hozaima, M. Sandhu, V. Panagia, and N. Dhalla, “Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2⁺ transport,” Archives of Biochemistry and Biophysics, vol. 387, no. 1, pp. 85–92, 2001.
View at: Publisher Site | Google Scholar
G. K. Singh, G. Rai, S. S. Chatterjee, and V. Kumar, “Beneficial effects of <i>Fumaria indica</i> on chronic stress-induced neurobehavioral and biochemical perturbations in rats,” Scientific Research, vol. 3, no. 1, pp. 49–60, 2012.
View at: Publisher Site | Google Scholar
S. Panda, A. Kar, P. Sharma, and A. Sharma, “Cardioprotective potential of _N_ ,α-l-rhamnopyranosyl vincosamide, an indole alkaloid, isolated from the leaves of _Moringa oleifera_ in isoproterenol induced cardiotoxic rats: In vivo and in vitro studies,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 4, pp. 959–962, 2013.
View at: Publisher Site | Google Scholar
W. Li, B. T. Altura, and B. M. Altura, “Differential effects of methanol on rat aortic smooth muscle,” Alcohol, vol. 16, no. 3, pp. 221–229, 1998.
View at: Publisher Site | Google Scholar
F. Pérez-Vizcaíno, A. L. Cogolludo, E. Villamor, and J. Tamargo, “Role of K⁺ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways,” British Journal of Pharmacology, vol. 123, no. 5, pp. 847–854, 1998.
View at: Publisher Site | Google Scholar
M. Heinrich, J. Mah, and V. Amirkia, “Alkaloids used as medicines: structural phytochemistry meets biodiversity-an update and forward look,” Molecules, vol. 26, no. 7, p. 1836, 2021.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Aimen Sajid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1155

Downloads

657

Citations